One of the pivotal discoveries supporting the concept of cancer reversion came from the groundbreaking work of Takahashi and Yamanaka, who demonstrated that differentiated somatic cells could be reprogrammed into iPSCs through the introduction of just four transcription factors (named Myc, Oct3/4, Sox2 and Klf4) [7]. The gene discussed is MYC; the disease is cancer.